The 53 rating InvestorsObserver gives to Stealth BioTherapeutics Corp (MITO) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 54 percent of stocks in the Biotechnology industry, MITO’s 53 overall rating means the stock scores better than 53 percent of all stocks.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 53 would rank higher than 53 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Stealth BioTherapeutics Corp Stock Today?
Stealth BioTherapeutics Corp (MITO) stock has gained 22.44% while the S&P 500 is down -0.04% as of 12:23 PM on Tuesday, Feb 9. MITO has risen $0.43 from the previous closing price of $1.93 on volume of 1,509,621 shares. Over the past year the S&P 500 has gained 16.76% while MITO has risen 1.29%. MITO lost -$0.80 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Stealth BioTherapeutics Corp (MITO) Stock.
